US Patent 7598078 Settings for recombinant adenoviral-based vaccines
Patent 7598078 was granted and assigned to Crucell on October, 2009 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7598078 Settings for recombinant adenoviral-based vaccines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.